QR-Code

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model

Ivermectin, an FDA-approved antiparasitic drug, has been reported to have in vitro activity against SARS-CoV-2. Increased off-label use of ivermectin for COVID-19 has been reported. We here assessed the effect of ivermectin in Syrian hamsters infected with the SARS-CoV-2 Beta (B.1.351) variant. Infe...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Caroline S. Foo, Rana Abdelnabi, Laura Vangeel, Steven De Jonghe, Dirk Jochmans, Birgit Weynand, Johan Neyts
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2022-03-01
Schriftenreihe:Microorganisms
Schlagworte:
COVID-19
ivermectin
molnupiravir
off-label use
hamster model
Online-Zugang:https://www.mdpi.com/2076-2607/10/3/633
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge